Pre-engraftment infectious complications and patient outcomes after allogeneic hematopoietic cell transplantation: a single-center experience from Lebanon

Abstract

Background: Infectious complications are significant causes of morbidity and mortality after allogeneic hematopoietic cell transplantation (allo-HCT). They occur variably over different periods, with scant data reported from Lebanon and neighboring countries. In this study, we described the pre-engraftment neutropenic phase, febrile episodes, and peri-transplant medical complications in patients undergoing allo-HCT at a tertiary-care hospital. Methods: This is a retrospective chart review of patients who underwent allo-HCT between 2007 and 2016 at Makassed General Hospital in Beirut, Lebanon. Data were extracted from medical records, the HCT registry, and medical laboratory logbooks. Results: One hundred and six patients were included, 75% having hematologic malignancies and 13% aplastic anemia. None received antibacterial prophylaxis with fluoroquinolones. Yet from conditioning chemotherapy till the say before HCT, 32% of the patients received broad-spectrum antibiotics (BSA) due to fever or infection. At the day of cell infusion, 41.5% of the patients were on BSA. Neutrophil engraftment failure was recorded in 8% of the patients. The cumulative incidence of pre-engraftment bacteremia and Gram-negative bacteremia was 14.3 and 7.1%, respectively. Aplastic anemia was an independent risk factor for pre-engraftment bacteremia [hazard ratio (HR) = 3.86, 95% confidence interval (CI) (1.29–11.5), P = 0.02]. The cumulative incidence of pre-engraftment pneumonia was 11.2%. Patient age significantly increased the risk of pre-engraftment pneumonia [HR = 12.35, 95% CI (1.27–120.50), P = 0.03]. Six-month post-transplant mortality reached 17% in our cohort. Myelodysplastic syndrome was the only significant parameter increasing the risk of death [HR = 3.40, 95% CI (1.05–10.98), P = 0.04]. Conclusion: The cumulative incidence of pre-engraftment bacteremia and pneumonia was 14.3% and 11.2% respectively in this cohort. Aplastic anemia predicted for the occurrence of bacteremia, increasing patient age contributed to the occurrence of pneumonia, and myelodysplastic syndrome increased the risk of death. © 2020, Springer-Verlag GmbH Germany, part of Springer Nature.

Description

Keywords

Allogeneic hematopoietic cell transplantation, Bacteremia, Mortality, Pneumonia, Pre-engraftment period, Adolescent, Adult, Aged, Aged, 80 and over, Child, Child, preschool, Female, Hematopoietic stem cell transplantation, Humans, Incidence, Infant, Infant, newborn, Lebanon, Male, Middle aged, Retrospective studies, Risk factors, Tertiary care centers, Transplantation, homologous, Young adult, Amikacin, Carbapenem derivative, Cephalosporin derivative, Cilastatin plus imipenem, Clindamycin, Colistimethate, Cyclosporine, Meropenem, Penicillin v, Piperacillin plus tazobactam, Posaconazole, Quinoline derived antiinfective agent, Teicoplanin, Tigecycline, Vancomycin, Voriconazole, Acute leukemia, Age, Allogeneic hematopoietic stem cell transplantation, Antibiotic sensitivity, Antibiotic therapy, Aplastic anemia, Article, Cohort analysis, Engraftment, Febrile neutropenia, Graft failure, Graft versus host reaction, Gram negative sepsis, Hematologic malignancy, Human, Infectious complication, Major clinical study, Mortality risk, Mycosis, Myeloablative conditioning, Myelodysplastic syndrome, Outcome assessment, Reduced intensity conditioning, Retrospective study, Risk factor, Allotransplantation, Newborn, Preschool child, Tertiary care center, Very elderly

Citation

Endorsement

Review

Supplemented By

Referenced By